DURATION diabetes therapy utilization: researching changes in A1C, weight and other factors through intervention with exenatide QW (extended-release exenatide, 2 mg, once weekly), EQW exenatide QW, HDL-C high density lipoprotein cholesterol, GLP-1 RA glucagon-like peptide-1 receptor agonist, LDL-C low density lipoprotein cholesterol, RCTs randomised controlled trials, T2DM type 2 diabetes mellitus, TZD thiazolidinediones Table 15
Each Mercedes C Class W204 Cruiser Front Lip Spoiler Air Dam undergoes inspection
Report on early implementation of demonstrations under the Financial Alignment Initiative
This information is valuable for healthcare professionals in optimising your injection technique or investigating potential underlying causes
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder